维普期刊资源整合服务平台（V6.5）

479篇 您的检索式：作者名="Manegold"

选中清除导出查看参考文献查看引证文献引用追踪共24页首页上一页第1页下一页末页 /24 跳转

	题名	作者	年代	出处	被引量
1	Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer显示文摘	Giorgio Scagliotti Thomas Brodowicz Frances A. Shepherd Christoph Zielinski Johan Vansteenkiste Christian Manegold Lorinda Simms Frank Fossella Katherine Sugarman Chandra P. Belani	2011	Journal of Thoracic Oncology2011，，1：	2
2	Treatment of elderly patients with non-small cell lung cancer 显示文摘	Manegold C	2001	Oncology (Hungtingt)2001，15，6：	1
3	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase Ⅲ trial-INTACT1 显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin Oncol2004，22，5：	1
4	Breaking the memory wall in Monet DB显示文摘	Boncz P A Kersten M L Manegold S	2008	Commun ACM2008，51，12：	1
5	Inhibition of cell proliferation by bacterial lipopolysaccharides in TLR4-positive epithelial cells:independence of nitric oxide and cytokine release显示文摘	Muller-Decker K Manegold G Butz H	2005	J Invest Dermatol2005，124，：	1
6	Advanced NSCLC:new cytostatic agents显示文摘	Paris A Kosmidis Christian Manegold	2003	Lung Cancer2003，41，：	1
7	Gemcitabine in non-small-cell lung cancer显示文摘	Manegold C Zatloukal P Krejcy k	2000	Invest New Drugs2000，18，1：	1
8	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial 2 intact1显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin Oncol2004，22，9：	1
9	Gemcitabine in non-small cell lung cancer(NSCLC) 显示文摘	Manegold C Zatloukal P Krejcy K	2000	Invest New Drugs2000，18，1：	1
10	Bevacizumab for the treatment of advanced non-small-cell lung cancer显示文摘	Manegold C		0，，：	1
11	Gemcitabine(Gemzar) in non-small cell lung cancer显示文摘	Manegold C	2004	Expert Rev Anticancer Ther2004，4，3：	1
12	Gefitinib in corn hination with gemcitabine and cisplatin in advanced non-small cell lung cancer:a phase III trial--INTACT 1显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin On- col2004，22，5：	1
13	Front - line treatment of advancednon - small - cell lung cancer with MTA ( LY231514, pemetrexed disodium, ALIMTA) andcisplatin : a mul- ticenter phase II trial显示文摘	Manegold C Gatzemeier U von Pawel J	2000	Ann Onco12000，11，4：	1
14	Randomized phase 1I trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer显示文摘	Manegold C Gravenor D Woytowitz D	2008	J Clin Oncol2008，26，24：	1
15	Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514,pometrexed disodium,ALIMTA) and cisplatin:a multicenter phase Ⅱ trial显示文摘	Manegold C Gatzemeier U Von Pawel J	2000	Ann Oncol2000，11，4：	1
16	Raltitrexed (Tomudex) and cisplatin in metastatic non-small cell lung cancer (NSCLC) : peliminary results of a Phase Ⅰ dose-escalation study 显示文摘	Manegold C Buchholz E Kloeppel R	1999	Eur J Cancer1999，35，4：	1
17	Randomized phase Ⅲ trial of gemcitabine/cisplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLG) 显示文摘	Manegold C Thatcher N Benner R J	2008	J Clin Oncol2008，26，：	1
18	Short - term treatment - related symptoms and quality of life: results from an international randomized phase III study of cispla- tin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung - Cancer Group and National Cancer Institute, Canada, Intergroup Study 显示文摘	Bottomley A Gaafar R Manegold C	2006	J Clin Oneol2006，24，9：	1
19	Phase Ⅱ study of two dose schedules of CERA ( continuous erythropoietin receptor activator ) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy显示文摘	Hirsh V Glaspy J Mainwaring P Manegold C Ramlau R Eid JE	2007	Trials2007，8，：	1
20	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase III trial--INTACT 1显示文摘	HERBST RS MANEGOLD C	2004	J Clin Oncol2004，22，5：	1

返回顶部每页显示：

共24页首页上一页第1页下一页末页 /24 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示